Peking University Third Hospital was founded in 1958 under the supervision of the Ministry of Health. It is affiliated with Peking University including 36 clinical departments and 1,752 clinic beds.

There are 1,264 beds in Beijing Haidian hospital.

During the past decade, Beijing Haidian hospital conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Beijing Haidian hospital" #1 sponsor was "Beijing Haidian Hospital" with 4 trials, followed by "Peking University People's Hospital" with 4 trials sponsored, "Capital Medical University" with 2 trials sponsored, "Asahi Kasei Pharma Corporation" with 1 trials sponsored and "Beijing Chao Yang Hospital" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Beijing Haidian hospital" #1 collaborator was "The First Hospital of Jilin University" with 4 trials as a collaborator, "Chinese PLA General Hospital" with 3 trials as a collaborator, "Peking University People's Hospital" with 3 trials as a collaborator, "Qilu Hospital of Shandong University" with 3 trials as a collaborator and "Affiliated Hospital of North Sichuan Medical College" with 2 trials as a collaborator. Other collaborators include 168 different institutions and companies that were collaborators in the rest 115 trials.

According to Clinical.Site data, the most researched conditions in "Beijing Haidian hospital" are "Familial Alzheimer Disease (FAD)" (2 trials), "Non-small Cell Lung Cancer" (2 trials), "Pneumothorax" (2 trials), "Alzheimer Disease" (1 trials) and "Alzheimer Disease, Late Onset" (1 trials). Many other conditions were trialed in "Beijing Haidian hospital" in a lesser frequency.

Most popular intervention types in "Beijing Haidian hospital" are "Drug" (5 trials), "Procedure" (5 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "All-trans retinoic acid" (1 trials), "Cohort Study； pathogen； clinical features" (1 trials), "DIPL" (1 trials), "Danazol" (1 trials) and "Durvalumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Beijing Haidian hospital" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Beijing Haidian hospital". undefined are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 1 completed trials in Beijing Haidian hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Beijing Haidian hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".